🔴 GRAIL is trading 4.6% down today with no clear company-specific catalyst

GRAIL is trading 4.6% down now at $78.75, with no clear company-specific announcement identified to explain the decline.

• Shares rose 7.78% to $82.54 on August 25, 2026.
• The latest major disclosed catalyst was the FDA’s planned September advisory meeting for Galleri, announced August 7, which previously sent shares higher.
• Positive biotech sentiment does not explain the weakness; the move appears most consistent with profit-taking or unexplained trading activity.